Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liuwei Dihuang Pill for Presbycusis With Shen-Yin Deficiency
NCT05125081Phase 2Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jan 2022
- Primary completion
- Aug 2024
- Modality
- Herbal formula
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in presbycusis comparing LDP group with placebo group (2 arms). Primary endpoint: Phonetically Balanced Maximum at 48 weeks. Started Jan 2022; status: completed.
02
Drugs
liu wei di huang wan
03
Conditions
presbycusis
Beyond the preview
Go deeper on NCT05125081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05125081.